CHICAGO ââ?¬â?? The global biotechnology industry will face many serious issues over the next year, ranging from ethical and regulatory fights to the rigors of engineering better biofuels and bioproducts. But few of those challenges will compare with what immediately confronts the 20,000 convention visitors at BIO ââ?¬â?¢06.
Office of Strategic Communication